EXHIBIT 10.05 AMENDMENT NO. 2 TO NOTE PURCHASE AGREEMENT THIS AMENDMENT NO. 2 (the "AMENDMENT"), dated as of January 28, 2003, is by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the "COMPANY"), and PYXIS INNOVATIONS INC., a Delaware...Note Purchase Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.1 STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10.3 AMENDMENT NO. 2 TO SECURITY AGREEMENT THIS AMENDMENT NO. 2 (the "AMENDMENT"), dated as of March 5, 2003, is by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the "COMPANY"), and PYXIS INNOVATIONS INC., a Delaware...Security Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.8 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the "AGREEMENT") is made as of March 5, 2003, by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the "COMPANY"), and PYXIS INNOVATIONS INC., a Delaware...Registration Rights Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
GUARANTYGuaranty • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Michigan
Pyxis Innovations Inc., a Delaware corporation, is a wholly owned subsidiary of Alticor Inc., a Michigan corporation ("Alticor").
EXHIBIT 10.10 AMENDMENT TO EMPLOYMENT AGREEMENT THIS AMENDMENT (the "AMENDMENT"), dated as of March 5, 2003, is made by and between INTERLEUKIN GENETICS, INC., a Delaware corporation ("EMPLOYER"), and FENEL ELOI, an individual ("EMPLOYEE"). Employer...Employment Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.12 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 (the "AMENDMENT"), dated as of March 5, 2003, is made by and between INTERLEUKIN GENETICS, INC., a Delaware corporation ("EMPLOYER"), and PAUL MARTHA, M.D., an individual...Employment Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
EXECUTION RESEARCH AGREEMENT This RESEARCH AGREEMENT (this "Agreement") is entered into as of March 5, 2003 (the "Effective Date") by and between Interleukin Genetics, Inc., a Delaware corporation having its principal office at 135 Beaver Street,...Research Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Michigan
EXHIBIT 10.9 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 (the "AMENDMENT"), dated as of March 5, 2003, is made by and between INTERLEUKIN GENETICS, INC., a Delaware corporation ("EMPLOYER"), and PHILIP R. REILLY, an individual...Employment Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
EXECUTION EXCLUSIVE LICENSE AGREEMENT In this Agreement, Interleukin Genetics, Inc., a Delaware Corporation having its principal office at 135 Beaver Street, Waltham, MA 02452 (hereafter "IG"), and Access Business Group International LLC, having...Exclusive License Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Michigan
EXHIBIT 10.13 FORM OF DIRECTOR INDEMNITY AGREEMENT THIS DIRECTOR INDEMNITY AGREEMENT ("AGREEMENT") is made as of March 5, 2003, by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the "CORPORATION"), and the undersigned director of the...Director Indemnity Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
